Company Filing History:
5 out of 639 
2 out of 43 
Years Active: 2022
Title: Nathalie Mugnier: Innovator in Cancer Diagnostics
Introduction
Nathalie Mugnier is a prominent inventor based in Lyons, France. She has made significant contributions to the field of cancer diagnostics, holding a total of 5 patents. Her innovative methods focus on the diagnosis and prognosis of various types of cancer, utilizing advanced molecular techniques.
Latest Patents
Among her latest patents, Nathalie has developed a method for the diagnosis or prognosis, in vitro, of lung cancer. This invention includes a step of detecting at least one expression product of at least one HERV nucleic acid sequence. It also involves the use of these isolated nucleic acid sequences as molecular markers, along with a kit that includes at least one binding partner specific for the expression products of the HERV nucleic acid sequences. Additionally, she has created a similar method for the diagnosis or prognosis, in vitro, of testicular cancer, which follows the same principles and methodologies.
Career Highlights
Nathalie Mugnier has worked with notable companies such as bioMérieux, Inc. and Hospices Civils de Lyon. Her experience in these organizations has allowed her to refine her skills and contribute to groundbreaking research in cancer diagnostics.
Collaborations
Throughout her career, Nathalie has collaborated with esteemed colleagues, including François Mallet and Philippe Perot. These partnerships have further enhanced her research and development efforts in the field.
Conclusion
Nathalie Mugnier is a trailblazer in the realm of cancer diagnostics, with a focus on innovative methods that leverage molecular biology. Her contributions are paving the way for advancements in early detection and treatment of cancer.